Oxybutynin is an anticholinergic drug that is used to improve your bladder's ability to store urine. In MS it may be used if you need to go to the toilet frequently, or if you have sudden urges to go to the toilet or find it difficult to 'hold on'. This is known as urinary frequency or urgency.

Remibrutinib is a Bruton's tyrosine kinase inhibitor (BTKi) being tested as a new treatment for relapsing remitting multiple sclerosis (MS).

Think there's no treatment for progressive MS? Think again! In this episode we uncover the truth with the insights of of neurologist Dr. Emma Tallantyre and explore what available options there are.

Hearing that your MS is progressing can feel overwhelming, but you’re not alone. Listen to our podcast for expert information and real stories.

From challenges to special moments: advanced MS comes with a whole heap of them both. Listen now to hear three different perspectives: a person living with advanced MS, a carer and a health professional.

Join us for a jargon busting, myth smashing podcast where we explore baffling multiple sclerosis terms and common misconceptions.

Take a look at the MS Trust Conference 2019 poster entries, which share a wide range of information relevant to MS practice.

What questions have the MS community been asking in 2024? We took to social media and analysed our helpline enquiries to find out.

Is public transport derailing your life? We caught up with Meg Barnett (Transport For All), Flora (MS Trust helpline), Richard Sprenger and Antoinette Mohamed on public transport tips, helpful information and all the latest resources.